Company intelligence / Profile preview

Improvision

Coventry, United Kingdom

Ownership: Private
Development stage: Other

Overview

Improvision was a leading provider of high-performance 3D and 4D imaging software and hardware solutions for life science research. The company was best known for its flagship products, Volocity and Openlab, which enabled researchers to visualize, analyze, and manage complex multi-dimensional biological data. Founded in the UK, Improvision's technology became a standard in confocal microscopy and cellular imaging. In 2007, the company was acquired by PerkinElmer to bolster its cellular imaging and analysis portfolio. Its software continues to be influential in the field of cell biology and drug discovery.

Industry: Pathology

Partnerships

ZeissLeica MicrosystemsNikonOlympus

Beyond the preview

Go deeper on Improvision.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Improvision.

Explore the full profile